Bullboard - Stock Discussion Forum Longeveron Inc LGVN

Healthcare Biotechnology

Longeveron Inc. is a clinical-stage biotechnology company. The Company is focused on developing cellular therapies for specific aging-related and life-threatening conditions. The Company's lead investigational product is the LOMECEL-B cell-based therapy product (Lomecel-B), which is derived from culture-expanded medicinal signaling cells (MSCs) that are sourced from bone marrow of young healthy... see more

Add To Watchlist

NDAQ:LGVN - Post Discussion

Longeveron Inc > Longeveron Announces Exercise of Warrants for $6.2 Million G

View:

Post by whytestocks on Apr 17, 2024 5:45pm

Longeveron Announces Exercise of Warrants for $6.2 Million G

JUST IN: $LGVN Longeveron Announces Exercise of Warrants for $6.2 Million Gross ProceedsMIAMI, April 17, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or the “Company”), a clinical stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart ...LGVN - Longeveron Announces Exercise of Warrants for $6.2 Million Gross Proceeds